Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03250338
What this trial is testing

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Arog Pharmaceuticals, Inc. 106
Not applicableStudy completedNCT02410252
What this trial is testing

Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin Lymphoma
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01736943
What this trial is testing

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Joseph Tuscano 25
Early research (Phase 1)WithdrawnNCT03752138
What this trial is testing

TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT04139434
What this trial is testing

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Who this might be right for
AML/MDSCMMLRelapse+3 more
Newave Pharmaceutical Inc 32
Testing effectiveness (Phase 2)Study completedNCT00003255
What this trial is testing

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 38
Testing effectiveness (Phase 2)Looking for participantsNCT06561152
What this trial is testing

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
Stanford University 20
Early research (Phase 1)Study completedNCT03625505
What this trial is testing

Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 61
Testing effectiveness (Phase 2)Study completedNCT00764231
What this trial is testing

A Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaExerciseFatigue+1 more
Toronto Rehabilitation Institute 40
Testing effectiveness (Phase 2)Study completedNCT03303339
What this trial is testing

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Cardiff Oncology 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT07651475
What this trial is testing

Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
R/R AML
Liping Dou 32
Testing effectiveness (Phase 2)Study completedNCT03068819
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 62
Early research (Phase 1)Study completedNCT03672695
What this trial is testing

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

Who this might be right for
Acute Myeloid Leukaemia
Institut de Recherches Internationales Servier 37
Not applicableStudy completedNCT06648512
What this trial is testing

Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Relapse
Exscientia AI Limited 91
Large-scale testing (Phase 3)Study completedNCT01147939
What this trial is testing

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Clavis Pharma 381
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Very early researchWithdrawnNCT07338357
What this trial is testing

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Who this might be right for
AML (Acute Myeloid Leukemia)CAR-T
First Affiliated Hospital of Guangxi Medical University
Not applicableEnded earlyNCT04858594
What this trial is testing

Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT04250051
What this trial is testing

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more
Northwestern University 2
Next Page